NCT00084721 2013-01-31Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerRoswell Park Cancer InstitutePhase 1 Completed2 enrolled
NCT00001693 2008-03-04Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and CarriersNational Institutes of Health Clinical Center (CC)Phase 1 Completed20 enrolled